- Home
- CAPR vs HBNC Comparison
CAPR vs HBNC Comparison
Compare CAPR & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- HBNC
- Stock Information
- Founded
- CAPR 2005
- HBNC 1873
- Country
- CAPR United States
- HBNC United States
- Employees
- CAPR N/A
- HBNC N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- HBNC Major Banks
- Sector
- CAPR Health Care
- HBNC Finance
- Exchange
- CAPR Nasdaq
- HBNC Nasdaq
- Market Cap
- CAPR 622.9M
- HBNC 692.0M
- IPO Year
- CAPR N/A
- HBNC N/A
- Fundamental
- Price
- CAPR $12.79
- HBNC $15.22
- Analyst Decision
- CAPR Strong Buy
- HBNC Hold
- Analyst Count
- CAPR 7
- HBNC 2
- Target Price
- CAPR $39.29
- HBNC $19.00
- AVG Volume (30 Days)
- CAPR 1.5M
- HBNC 162.6K
- Earning Date
- CAPR 03-19-2025
- HBNC 04-23-2025
- Dividend Yield
- CAPR N/A
- HBNC 4.21%
- EPS Growth
- CAPR N/A
- HBNC N/A
- EPS
- CAPR N/A
- HBNC 0.48
- Revenue
- CAPR $23,228,045.00
- HBNC $183,718,000.00
- Revenue This Year
- CAPR N/A
- HBNC $24.52
- Revenue Next Year
- CAPR $74.85
- HBNC $18.53
- P/E Ratio
- CAPR N/A
- HBNC $31.51
- Revenue Growth
- CAPR 65.33
- HBNC N/A
- 52 Week Low
- CAPR $3.52
- HBNC $11.18
- 52 Week High
- CAPR $23.40
- HBNC $19.18
- Technical
- Relative Strength Index (RSI)
- CAPR 42.76
- HBNC 32.14
- Support Level
- CAPR $11.75
- HBNC $16.05
- Resistance Level
- CAPR $16.17
- HBNC $16.87
- Average True Range (ATR)
- CAPR 1.51
- HBNC 0.52
- MACD
- CAPR -0.18
- HBNC -0.19
- Stochastic Oscillator
- CAPR 22.96
- HBNC 5.61
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.